Rancho Sahuarita Cancer Walk & Sharpe Brain Cancer Research Awards
Taking Steps to Fight Cancer
Just because the walk is over, it doesn’t mean we stop fighting!
Thank you to all those who came out to our inaugural Rancho Sahuarita 5K run/walk, presented by the Today is a Good Day Foundation. Your participation and contributions helped move the needle towards finding a cure, by assisting the National Brain Tumor Society in its efforts to fund innovative cancer research. Deadly brain tumors strike men, women and children at any time of their lives, and are the leading cause of cancer-related death for children younger than 14.
SHARPE BRAIN CANCER RESEARCH AWARDS
Unlike other fundraising efforts, where you are not sure where the money goes, Bob Sharpe, the founder of Rancho Sahuarita and a brain tumor survivor, partnered with NBTS to ensure 100% of the money raised goes towards innovative brain cancer research.
Together, they have created the Sharpe Brain Cancer Research Awards, where 10 of the top research institutions in the country have been invited to submit their best ideas on how to cure brain cancer. The top 3 ideas will be awarded monetary prizes to fund critical research, (1st place will receive $100,000, 2nd place will receive $50,000 and 3rd place will receive $25,000.)
We are optimistic that this initiative will produce significant advances based on the brain cancer research that we’re funding. These projects include:
1) Developing effective therapeutics of targeted- and Immuno-therapy GBM,” PI: Jean Zhao, PhD, Co-PI: Patrick Wen, MD, Dana-Farber Cancer Institute
2) Pritumumab Immunotherapy for Glioblastoma, PI: Santosh Kesari, MD, PhD, John Wayne Cancer Institute
3) Targeting the glioma immune environment by creating tertiary lymphoid organs, Co-PIs: Susan Chang, MD and Hideho Okada, MD, PhD, University of California, San Francisco
4) Identifying and targeting metabolic co-dependency pathways in GBM: an unbiased systematic approach, PI: Paul Mischel, Ludwig Institute for Cancer Research
5) Elucidating the dynamics of immune-reactive signatures in glioblastoma, PI: Timothy Cloughesy, MD, Co-PI: David Nathanson, PhD, University of California, Los Angeles
6) In-situ mapping of GBM tumor microenvironment, PI: Ingo Mellinghoff, MD, Co-PI: Travis Hollmann, MD, PhD, Memorial Sloan Kettering Cancer Center
7) Combining PVSRIPO Immunotherapy with Chemotherapy for the Treatment of Recurrent GBM,PI: Matthias Gromeier, MD, Co-PI: Annick Desjardins, MD, Duke University
8) Immunotherapy for Brain Tumors Through APOBEC3B-induced Neo-epitope Generation in Combination with Immune Checkpoint Blockade, PI: Richard Vile, PhD, Co-PI: Brian Patrick ’Neill, MD, Mayo Clinic
9) PDL1 expression and regulation in glioblastoma stem cells, PI: Veerakumar Balasubramaniyan, Co-PI: John de Groot, MD, University of Texas MD Anderson Cancer Center
10) Targeting IL-6 to strengthen immunotherapy for GBM,PI: Yi Fan, MD PhD, Co-PI: Steven Brem, MD, University of Pennsylvania
DONATE TODAY AND HELP US CONTINUE THE FIGHT AGAINST BRAIN TUMORS!